Text Size

Causes, Analysis of the Sub-evaluating Coronary Syndromes Acute and Disparities in France in Women (CASSANDRE)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Stephane MANZO-SILBERMAN, French Cardiology Society
ClinicalTrials.gov Identifier:
NCT01394549
First received: July 13, 2011
Last updated: June 20, 2012
Last verified: June 2012
History of Changes
  Purpose

Despite efforts of learned societies, community cardiology and more generally of most players in the health, cardiovascular diseases continue to be the leading cause of death among women in France and all over the Western world, there where they fell to second place among men. Clinical practice and the disparity between the sexes are still insufficiently known.

Multicenter observational study on a cross-week comparative basis with men


Condition
Coronary Acute Syndrome

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Causes, Analysis of the Sub-evaluating Coronary Syndromes Acute and Disparities in France in Women

Further study details as provided by French Cardiology Society:

Primary Outcome Measures:
  • Clinical practices [ Time Frame: 1 day ] [ Designated as safety issue: No ]
    To assess clinical practices and disparities between men and women in the management of acute coronary syndrome


Enrollment: 319
Study Start Date: June 2011
Study Completion Date: March 2012
Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)
Groups/Cohorts
Cardiology
The study includes all patients hospitalized for acute coronary syndrome during the week selected and who agreed to participate in the study.

Detailed Description:

In France, as in other industrialized countries, ischemic heart disease is a major cause of morbidity and mortality in women. Work to improve epidemiological knowledge, prevention, screening, risk stratification and treatment of ischemic heart disease in women has a potential impact on all the issues listed.

There is therefore a double challenge:

  • A public health issue to alert the female population on cardiovascular risk and its consequences, while the female population does not feel concerned by the potential danger.
  • A challenge for health professionals so that they have the same thing vis-à-vis the cardiovascular prevention among women and whatever their field of practice.
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

The study will be conducted in cardiac services regardless of the type of hospital where they are

Criteria

Inclusion Criteria:

  • Women all patients and / or men regardless of age
  • Admitted to a cardiology department (in the intensive care unit or cardiology traditional) week of the survey,
  • Having presented an acute coronary syndrome, regardless of the type with or without ST segment above, with or without elevated troponin, complicated or not, regardless of its support invasive or conservative,
  • Patients who agreed to participate in the study.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01394549

Locations
France
CHU Amiens
Amiens, France
Sponsors and Collaborators
French Cardiology Society
  More Information

Publications:

Responsible Party: Stephane MANZO-SILBERMAN, Assistant Professor, French Cardiology Society
ClinicalTrials.gov Identifier: NCT01394549     History of Changes
Other Study ID Numbers: 11320
Study First Received: July 13, 2011
Last Updated: June 20, 2012
Health Authority: France : National Commission on Informatics and Freedoms

ClinicalTrials.gov processed this record on May 22, 2013